Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
APLT | US
Overview
Corporate Details
- ISIN(s):
- US03828A1016
- LEI:
- Country:
- United States of America
- Address:
- 545 FIFTH AVENUE, SUITE 1400, 10017 NEW YORK
- Sector:
- Manufacturing
Description
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for rare diseases with high unmet medical needs. The company's pipeline is centered on creating transformative treatments by targeting validated molecular pathways. Its primary focus is on the development of aldose reductase inhibitors (ARIs) for a range of conditions. Key therapeutic areas include rare metabolic and central nervous system (CNS) diseases, such as Classic Galactosemia, Sorbitol Dehydrogenase (SORD) deficiency, and PMM2-CDG, as well as Diabetic Cardiomyopathy. The company's approach aims to accelerate the drug development timeline by utilizing biomarkers and established clinical endpoints.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Applied Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Applied Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Applied Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
